New Artificial Intelligence based blood test developed at John Hopkins University accurately detects the presence and stage of liver cancer

Artificial intelligence and machine learning technologies in the form of Software as a Medical Device (SaMD) are transforming healthcare through their capabilities to derive new and important insights from the vast amounts of data being generated during the delivery of health care every day. Today we are covering an exciting new SaMD breakthrough from a […]

BML Technology Founder and Managing Director Marc Saab in North Carolina for the official launch of the NC Health Innovation District (NCHID) initiative

We are excited that our Founder and Managing Director  Marc Saab was in North Carolina to mark the official launch of the NC Health Innovation District (NCHID). The NCHID seeks to leverage the growing ecosystem of digital health across the state to address health inequities and pave the way for community health and wealth. The […]

Insights into the US Food and Drug Administration’s (FDA) evolving regulatory framework for Artificial Intelligence, Machine Learning and Software as a Medical Device (SaMD)

It is no secret that the digital health industry is continuing to expand at an explosive rate and that companies in this field are experiencing a once in a lifetime opportunity at true disruption. The digital transformation of healthcare is real and picking up speed as an increasing number of stakeholders come to understand the […]